Vertex Pharmaceuticals Inc (VRTX): Revenue
$12.00B
Year ended 2025-12-31
$12.59B
Trailing 12 months to 2026-06-30
+10.4%
3-year compound annual growth
+14.1%
5-year compound annual growth
+27.8%
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $12.00B | +8.9% | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | $11.02B | +11.7% | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | $9.87B | +10.5% | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | $8.93B | +17.9% | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | $7.57B | +22.1% | 2024-02-15, From 2021-01-01 |
| 2020-12-31 | $6.21B | +49.1% | 2023-02-10, From 2020-01-01 |
| 2019-12-31 | $4.16B | +36.6% | 2022-02-09, From 2019-01-01 |
| 2018-12-31 | $3.05B | +22.5% | 2021-02-11, From 2018-01-01 |
| 2017-12-31 | $2.49B | +46.2% | 2020-02-13, From 2017-01-01 |
| 2016-12-31 | $1.70B | +64.9% | 2019-02-13, From 2016-01-01 |
| 2015-12-31 | $1.03B | +77.9% | 2018-02-15, From 2015-01-01 |
| 2014-12-31 | $580.41M | -52.1% | 2017-02-23, From 2014-01-01 |
| 2013-12-31 | $1.21B | -20.6% | 2016-02-16, From 2013-01-01 |
| 2012-12-31 | $1.53B | +8.3% | 2015-02-13, From 2012-01-01 |
| 2011-12-31 | $1.41B | +883.9% | 2014-02-11, From 2011-01-01 |
| 2010-12-31 | $143.37M | +40.7% | 2013-03-01, From 2010-01-01 |
| 2009-12-31 | $101.89M | -41.9% | 2012-02-22, From 2009-01-01 |
| 2008-12-31 | $175.50M | n/a | 2011-02-17, From 2008-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $12.00B | +8.9% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $10.27B | +6.7% |
| Viatris Inc (VTRS) | 2025-12-31 | $14.30B | -3.0% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $14.34B | +1.0% |
| Zoetis Inc. (ZTS) | 2025-12-31 | $9.47B | +2.3% |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $17.26B | +4.3% |
| Organon & Co. (OGN) | 2025-12-31 | $6.22B | -2.9% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $5.34B | +40.2% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $4.71B | +6.2% |
Compare VRTX, BHC, VTRS, REGN side by side · Screen every company in Pharmaceutical Preparations ↗